Anna Angelousi
Overview
Explore the profile of Anna Angelousi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
735
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Chrysavgis L, Adamantou M, Angelousi A, Cholongitas E
Eur J Clin Invest
. 2023 Oct;
54(2):e14108.
PMID: 37837304
Background: Testosterone is an important anabolic hormone responsible for maintaining body composition and muscle mass and circulates mostly albumin-bound, or sex hormone binding globulin (SHBG)-bound or free in the plasma....
12.
Mytareli C, Athanasouli F, Andreadaki E, Thanasoula F, Angelousi A
Hormones (Athens)
. 2023 Oct;
23(1):113-120.
PMID: 37792214
Purpose: The role of endocannabinoids (ECs) in the regulation of the hypothalamic-pituitary-adrenocortical axis has already been studied; however, data are scarce in humans. The aim of our study was to...
13.
Faucz F, Horvath A, Assie G, Almeida M, Szarek E, Boikos S, et al.
Endocr Relat Cancer
. 2023 Aug;
30(10).
PMID: 37578265
Gastrointestinal stromal tumors (GISTs) are mesenchymal neoplasms, believed to originate from the interstitial cells of Cajal (ICC), often caused by overexpression of tyrosine kinase receptors (TKR) KIT or PDGFRA. Here,...
14.
Angelousi A, Liapis G, Gazouli M, Kofotolios I, Sakellariou S, Boletis I, et al.
Mol Med Rep
. 2023 Jul;
28(3).
PMID: 37477126
Glucocorticoid receptor (GR) is expressed in normal renal podocytes; however, its expression differs among renal diseases. The expression of GR as well as its epigenetic regulators microRNA (miR)30a, miR24 and...
15.
Tsoli M, Koumarianou A, Angelousi A, Kaltsas G
Best Pract Res Clin Endocrinol Metab
. 2023 Jun;
37(5):101785.
PMID: 37336711
The management of neuroendocrine tumors (NETs) represents a clinical challenge due to heterogeneity of their clinical behaviour, molecular biology and response to treatment. Over the years, several circulating biomarkers have...
16.
Karapanagioti A, Nasiri-Ansari N, Moustogiannis A, Trigas G, Zografos G, Aggeli C, et al.
Endocrine
. 2023 May;
81(2):357-367.
PMID: 37221428
Purpose: CHCHD2 is an antiapoptotic mitochondrial protein acting through the BCL2/BAX pathway in various cancers. However, data on the regulatory role of CHCHD2 in adrenal tumourigenesis are scarce. Methods: We...
17.
Tsoli M, Daskalakis K, Wedin M, Angelousi A, Povlsen S, Srirajaskanthan R, et al.
J Neuroendocrinol
. 2023 Apr;
35(4):e13269.
PMID: 37102337
Pancreatic metastases (PMs) from neuroendocrine neoplasms (NENs) are rare but the increased sensitivity of new diagnostic tools such as Ga-DOTATATE PET/CT has resulted in their increased recognition at initial diagnosis...
18.
Mytareli C, Ziogas D, Karampela A, Papalexis P, Siampanopoulou V, Lafioniatis A, et al.
Cancers (Basel)
. 2023 Apr;
15(7).
PMID: 37046677
Immune checkpoint inhibitors (ICIs) have been approved for the treatment of many cancers, either in adjuvant or metastatic settings. Regarding safety, endocrine adverse events (AEs) are some of the most...
19.
Siampanopoulou V, Tasouli E, Angelousi A
Curr Opin Endocrinol Diabetes Obes
. 2023 Apr;
30(3):141-153.
PMID: 37036291
Purpose Of Review: Adrenal insufficiency (AI) is the clinical manifestation of deficient production of glucocorticoids with occasionally deficiency also in mineralocorticoids and adrenal androgens and constitutes a fatal disorder if...
20.
Alexandraki K, Angelousi A, Chatzellis E, Chrisoulidou A, Kalogeris N, Kanakis G, et al.
J Pers Med
. 2023 Feb;
13(2).
PMID: 36836538
Background: Somatostatin analogues (SSAs) are the cornerstone of treatment for carcinoid syndrome (CS)-related symptoms. The aim of this systematic review and meta-analysis is to evaluate the percentage of patients achieving...